VSee Health sells convertible note for $300,000 to Labrys Fund II
VSee Health agrees to sell a convertible promissory note with a $336,000 principal amount and $300,000 purchase price to Labrys Fund II on June 30, 2026, for legal and due diligence fees. Stock offering.
AI-generated summary for informational purposes only. Always verify against the original filing. Not investment advice. BriefTape is not a registered investment adviser.
Get real-time financial news in your trading bot or app
GET FREE KEY — 10,000 calls/day